Objective To explore the effects of acupuncture bloodletting combined with Tongfu Huatan Decoction on consciousness recovery time and electroencephalogram in patients with hemorrhagic stroke.

Methods A total of 100 patients with hemorrhagic stroke were randomly divided into control group and study group, with 50 patients in each group. The control group was treated with oral administration of Tongfu Huatan Decoction, while the study group received combined treatment of acupuncture bloodletting and Tongfu Huatan Decoction. Serological indicatorsN-terminal pro-brain natriuretic peptide (NT-proBNP), central nervous system-specific protein (S100β), aquaporin (AQP-1), and angiogenin 1 (Ang-1), consciousness disturbance scoresGlasgow Coma Scale (GCS), Full Outline of Unresponsiveness (FOUR), and Coma Recovery Scale-revised (CRS-R), electroencephalogram improvement, cerebral blood perfusion indicatorscerebral blood flow (CBF), cerebral blood volume (CBV), consciousness recovery time, and the occurrence of adverse reactions and complications were analyzed before and after treatment in both groups.

Results Before treatment, there were no statistically significant differences in all indicators in two groups (P>0.05). After treatment, the study group showed decreased levels of serum NT-proBNP, S100β, AQP-1, and Ang-1 in two groups, and showed significant differences between two groups (P < 0.05). The scores of GCS, FOUR, and CRS-R, as well as the levels of CBF and CBV increased in two groups, with more significant increase in the study group (P < 0.05). The improvement of electroencephalogram in the study group was significantly better, and the consciousness recovery time was shorter than that in the control group (P < 0.05). However, there were no statistically significant differences in adverse reactions and complications between the two groups (P>0.05).

Conclusion Acupuncture bloodletting combined with Tongfu Huatan Decoction can enhance cerebral function, reduce cerebral damage, and shorten consciousness recovery time in patients with hemorrhagic stroke.